Neuroimaging of mitochondrial disease

Mitochondrion

Volumn 8, Issue 5-6, 2008, Pages 396-413

  Saneto, Russell P ^a   Friedman, Seth D ^a   Shaw, Dennis W W ^a  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Brain; Magnetic resonance imaging (MRI); Magnetic resonance spectroscopy (MRS); Mitochondrial disease; Neuroimaging

Indexed keywords

CELL NUCLEUS DNA; CHOLINE; CREATINE; DICHLOROACETIC ACID; INOSITOL; LACTIC ACID; MITOCHONDRIAL DNA; SUCCINIC ACID; TRANSFER RNA; UBIDECARENONE; VALPROIC ACID;

ALPERS DISEASE; AMINO ACID SUBSTITUTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG RESPONSE; DRUG TOLERABILITY; GENE MUTATION; HUMAN; KEARNS SAYRE SYNDROME; KETOGENIC DIET; LEIGH DISEASE; LEUKODYSTROPHY; MELAS SYNDROME; MITOCHONDRIAL ENERGY TRANSFER; MNGIE SYNDROME; NEUROIMAGING; NEUROPATHOLOGY; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE PHOSPHORYLATION; PEARSON SYNDROME; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SEIZURE;

DIFFUSE CEREBRAL SCLEROSIS OF SCHILDER; HUMANS; KEARNS-SAYER SYNDROME; LEIGH DISEASE; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MELAS SYNDROME; MITOCHONDRIAL DISEASES; MITOCHONDRIAL ENCEPHALOMYOPATHIES;

EID: 54949094371     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2008.05.003     Document Type: Review

References (104)

1. Abe K. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 53 (2004) 2458
2. Abu-Amero K.K., Bosley T.M., Bohlega S., and Hansen E. Mitochondrial T9957C mutation in association with NAION and seizures but not MELAS. Ophthalmic Genet. 26 (2005) 31-36
3. Ackrel l.B.A.C., Johnson M.K., Gunsalus R.P., and Cecchini G. Structure and function of succinate dehydrogenase and fumarate reductase. In: Muller F. (Ed). Biochemistry of Flavoenzymes (1992), CRC, Boca Raton, FL 229-297
4. Apostolova L.G., White M., Moore S.A., and Davis P.H. Deep white matter pathologic features in watershed regions: a novel pattern of central nervous system involvement in MELAS. Arch. Neurol. 62 (2005) 1154-1156
5. Barbiroli B., Frassineti C., Martinelli P., Lotti S., Lodi R., Cortelli P., and Montagna P. Coenzyme Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy. Cell. Mol. Biol. (Noisy-le-grand) 43 (1997) 741-749
6. Barbiroli B., Montagna P., Martinelli P., Lodi R., Iotti S., Cortelli P., Funicello R., and Zaniol P. Detective brain energy metabolism shown by in vivo 31 P MR spectroscopy in 28 patients with mitochondrial cytopathies. J. Cereb. Blood Flow Metab. 13 (1993) 469-474
7. Bardosi A., Creutzfeldt W., DiMauro S., Filgenhauer K., Friede F.I., Goebel H.H., Kohlschutter A., Mayer G., Rahlf G., Servidei S., Van Lessen G., and Wetterling T. Myo-neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol. 74 (1987) 248-258
8. Barkovich A.J., Good W.V., Koch T.K., and Berg B.O. Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR Am. J. Neuroradiol. 14 (1993) 1119-1137
9. Barragan-Campos H.M., Valee J.-N., Lo D., Barrera-Ramirez F., Argote-Greene M., Sanchez-Guerrero J., Estanol B., Guillevin R., and Chiras J. Brain magnetic resonance imaging findings in patients with mitochondrial cytopathies. Arch. Neurol. 62 (2005) 737-742
10. Bernier F.P., Boneh A., Dennett X., Chow C.W., Cleary M.A., and Thornburn D.R. Diagnostic criteria for respiratory chain disorders in adult and children. Neurology 59 (2002) 1406-1411
11. Bianchi M.C., Tosetti M., Battini R., Leuzzi V., Alessandri M.G., Carducci C., Antonozzi I., and Cioni G. Treatment monitoring of brain creatine deficiency syndromes: a 1H and 31P-MR spectroscopy study. AJNR Am. J. Neuroradiol. 28 (2007) 548-554
12. Bianchi M.C., Tosetti M., Battini R., Manca M.L., Mancuso M., Cioni G., Canapicchi R., and Sicilliano G. Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic relevance. AJNR Am. J. Neuroradiol. 24 (2003) 1958-1966
13. Bluml S., Moreno A., Hwang J.H., and Ross B.D. 1-(13)C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders. NMR Biomed. 14 (2001) 19-32
14. Boddaert N., Romano S., Funalot B., Rio M., Sarzi E., Lebre A.S., Bahi-Buisson N., Valayannopoulos V., Desguerre I., Seidenwurm D., Brunelle F., Brami-Zylberberg F., Rotig A., Munnich A., and de Lonlay P. 1H MRS spectroscopy evidence of cerebellar high lactate in mitochondrial respiratory chain deficiency. Mol. Genet. Metab. 93 (2008) 85-88
15. Brockman K., Bjornstad A., Dechent P., Korenke C.G., Smeitink J., Trijbels J.M., Athanassopoulou S., Villagran R., Skjildal O.H., Wilichowski E., Frahm J., and Hanefeld F. Succinate in dystrophic white matter a proton magnetic resonance spectroscopy finding characteristic for complex II deficiency. Ann. Neurol. 52 (2002) 38-46
16. Burgeois M., Goutieres F., Chretien D., Rustin P., Munnich A., and Aicardi J. Deficiency in complex II of the respiratory chain, presenting as a leukodystrophy in two sisters with Leigh syndrome. Brain Dev. 14 (1992) 404-408
17. Cady E.B., Lorek A., Penrice J., Reynolds E.O., Iles R.A., Burns S.P., Coutts G.A., and Cowan F.M. Detection of propan-1,2-diol in neonatal brain by in vivo proton magnetic resonance spectroscopy. Magn. Reson. Med. 32 (1994) 764-767
18. Castillo M., Kwock L., and Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR Am. J. Neuroradiol. 16 (1995) 233-239
19. Choi C., Sunwoo I.N., Kim H.S., and Kim D.I. Transient improvement of pyruvate metabolism after coenzyme Q therapy in Kearns-Sayre syndrome: MRS study. Yonsei Med. J. 41 (2000) 676-679
20. Chu B.C., Terae S., Takahashi C., Kikuchi Y., Miyasaka K., Abe S., Minowa K., and Sawamura T. MRI of the brain in the Kearns-Sayre syndrome: report of four cases and a review. Neuroradiology 41 (1999) 759-764
21. Clark J.B. N-Acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev. Neurosci. 20 (1998) 271-276
22. Clark J.M., Marks M.P., Adalsteinsson E., Spielman D.M., Shuster D., Horouplan D., and Albers G.W. MELAS: clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Neurology 46 (1996) 223-227
23. De Stefano N., Matthews P.M., Ford B., Genge A., Karpati G., and Arnold D.L. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 45 (1995) 1193-1198
24. DiMauro S. Mitochondrial diseases. Biochim. Biophys. Acta 1658 (2004) 80-88
25. Dinopoulos A., Cecil K.M., Schapiro M.B., Papadimitriou A., Hadjigeorglou G.M., Wong B., de Grauw T., and Egelhoff J.C. Brain MRI and proton MRS findings in infants and children with respiratory chain defects. Neuropediatrics 36 (2005) 290-301
26. Farina L., Chiapparine L., Uziel G., Bugiani M., Zeviani M., and Savoiardo M. MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations. AJNR Am. J. Neuroradiol. 23 (2002) 1095-1100
27. Feng F., You H., Gao J., Li X.Z., Meng C.L., Sun H.Y., Jin Z.Y., and Gao Y.P. Evaluation of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes with magnetic resonance imaging and proton magnetic resonance spectroscopy. Chin. Med. Sci. J. 21 (2006) 234-238
28. Furuya H., Sugimura T., Yamada T., Hayashi K., and Kobayashi T. A case of incomplete Kearns-Sayre syndrome with a stroke like episode. Rinsho Shinkeigaku 37 (1997) 680-684
29. Garroway A., Grannell P., and Mansfield P. Image formation in NMR by selective irradiative process. J. Phys. C Solid State Phys. 7 (1974) 457-462
30. Goto Y., Nonaka I., and Horai S. A mutation in the tRNA leu (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348 (1990) 651-653
31. Gruetter R. In vivo 13C NMR studies of compartmentalized cerebral carbohydrate metabolism. Neurochem. Int. 41 (2002) 143-154
32. Hakonen A.H., Isohanni P., Paetau A., Herva R., Suomalainen A., and Lonnqvist T. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 130 (2006) 3032-3040
33. Hass R.H., Parikh S., Falk M.J., Saneto R.P., Wolf N.I., Darin N., and Cohen B.H. Guidelines for the generalist on the diagnosis of mitochondrial disease. Pediatrics 120 (2007) 1326-1333
34. Harding B.N. Progressive neuronal degeneration of childhood with liver diseases (Alpers-Huttenlocher syndrome): a personal review. J. Child Neurol. 5 (1990) 273-287
35. Hirano M., and Pavlakis S.G. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J. Child Neurol. 9 (1994) 4-13
36. Horvath R., Gudson G., Ferrari G., Futterer N., Ahola S., Lamantea E., Prokisch H., Lochmuller H., McFarland R., Ramesh V., Klopstock T., Freisinger P., Salvi F., Mayr J.A., Santer R., Tesarova M., Zeman J., Udd B., Taylor R.W., Turnbull D., Hanna M., Fialho D., Suomalainen A., Zeviani M., and Chinnery P.F. Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene. Brain 129 (2006) 1674-1684
37. Isobe T., Matsumura A., Anno I., Kawamura H., Shibata Y., Muraishi H., and Minami M. Lactate quantification by proton magnetic resonance spectroscopy using a clinical MRI machine: a basic study. Australas. Radiol. 51 (2007) 330-333
38. Jaksch M., Horvath R., Horn N., Auer D.P., Macmillan C., Peters J., Gerbitz K.D., Kraegeloh-Mann I., Muntau A., Karcagi V., Kalmanchey R., Lochmuller H., Shoubridge E.A., and Freisinger P. Homozygosity (E140K) in SCO2 causes delayed infantile onset of cardiomyopathy and neuropathy. Neurology 57 (2001) 1440-1446
39. Janssen R.J.R.J., Nijtmans I.G., van den Heuvel L.P., and Smeitink J.A.M. Mitochondrial complex I: structure, function and pathology. J. Inherit. Metab. Dis. 29 (2006) 499-515
40. Jeppesen T.D., Schwartz M., Hansen K., Danielsen E.G., Wibrand F., and Vissing J. Late onset of stroke-like episode associated with a 3256C->T point mutation of mitochondrial DNA. J. Neurol. Sci. 214 (2003) 17-20
41. Kang H.-C., Lee Y.-M., Kim H.D., Lee J.S., and Slama A. Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia 48 (2008) 82-88
42. Kapeller P., Fazekas F., Offenbacher H., Stollberger R., Schmidt R., Bergloff J., Radner H., Fazekas G., and Schafhalter-Zoppoth I. Magnetic resonance imaging and spectroscopy of progressive cerebral involvement in Kearns Sayre syndrome. J. Neurol. Sci. 135 (1996) 126-130
43. Keevil S.F. Spatial localization in nuclear magnetic resonance spectroscopy. Phys. Med. Biol. 51 (2006) 579-636
44. Kearns T.P., and Sayre G.P. Retinitis pigmentosa, external ophthalmoplegia and complete heart block. Arch. Ophthalmol. 60 (1958) 280-289
45. Kim H.S., Kim D.I., Lee B.I., Jeong E.K., Choi C., Lee J.D., Yoon P.H., Kim E.J., Kim S.H., and Yoon Y.K. Diffusion-weighted image and MR spectroscopic analysis of a case of MELAS with repeated attacks. Yonsei Med. J. 42 (2001) 128-133
46. Kimura S., Ohtuki N., Nezu A., Tanaka M., and Takeshita S. Clinical and radiologic improvements in mitochondrial encephalomyopathy following sodium dichloroacetate therapy. Brain Dev. 19 (1997) 535-540
47. Kingsley P.B., Shah T.C., and Woldenberg R. Identification of diffuse and focal brain lesions by clinical magnetic resonance spectroscopy. NMR Biomed. 19 (2006) 435-462
48. Kuwabara T., Watanabe H., Tanaka K., Tsuji S., Ohkubo M., Ito T., Sakai K., and Yuasa T. Mitochondrial encephalomyopathy: elevated visual cortex lactate unresponsive to Photic stimulation-a localized 1H-MRS study. Neurology 44 (1994) 557-559
49. Lange T., Dydak U., Roberts T.P., Rowley H.A., Bjeljac M., and Boesiger P. Pitfalls in lactate measurements at 3 T. AJNR Am. J. Neuroradiol. 27 (2006) 895-901
50. Larsson N.-G., Holme E., Kristiansson B., Oldfors A., and Tulinius M. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr. Res. 28 (1990) 131-136
51. Lauterbur P.C. Image formation by induced local interactions: examples of employing nuclear magnetic resonance. Nature 242 (1973) 190-191
52. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J. Neurol. Neurosurg. Psychiatry 14 (1951) 216-221
53. Lerman-Sagie T., Leshinsky-Silver E., Watemberg N., Luckman Y., and Lev D. White matter involvement in mitochondrial diseases. Mol. Genet. Metab. 84 (2005) 127-136
54. Leutner C., Layer G., Zierz S., Solymosi L., Dewes W., and Reiser M. Cerebral MR in ophthalmoplegia plus. AJNR Am. J. Neuroradiol. 15 (1994) 681-687
55. Lin D.D., Crawford T.O., and Baker P.B. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am. J. Neuroradiol. 24 (2003) 33-41
56. Lodi R., Montagna P., Iotti S., Zaniol P., Barboni P., Puddu P., and Barbiroli B. Brain and muscle energy metabolism studied in vivo by 31P-magnetic resonance spectroscopy in NARP syndrome. J. Neurol. Neurosurg. Psychiatry 57 (1994) 1492-1496
57. Majoie C.B., Akkerman E.M., Blank C., Barth P.G., Poll-The B.T., and den Heeten G.J. Mitochondrial encephalomyopathy comparison of convention MR imaging with diffusion-weighted and diffusion tensor imaging case report. AJNR Am. J. Neuroradiol. 23 (2002) 813-816
58. Malfatti E., Bugiani M., Ivernizzi F., Fischinger-Moura de Souza C., Farina L., Carrara F., Lamantea E., Antozzi C., Confalonieri P., Sanseverino M.T., Glugliani R., Uziel G., and Zeviani M. Novel mutations of ND genes in complex I deficiency associated with mitochondrial encephalopathy. Brain 130 (2007) 1894-1904
59. Maricich S.M., Azizi P., Jones J.Y., Morriss M.C., Hunter J.V., Smith E.O., and Miller G. Myelination as assessed by conventional MR imaging is normal in young children with idiopathic developmental delay. AJNR Am. J. Neruoradiol. 28 (2007) 1602-1605
60. Marti R., Nishigaki Y., Vila M.R., and Hirano M. Alteration of nucleotide metabolism: a new mechanism for mitochondrial disorders. Clin. Chem. Lab. Med. 41 (2003) 845-851
61. Matthews P., Tampieri D., Barkovich S., Andermann F., Silver K., Chityat D., and Arnold D.L. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology 41 (1991) 1043-1046
62. McShane M.A., Hammans S.R., Sweeney M., Holt I.J., Beattie T.J., Brett E.M., and Harding A.E. Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am. J. Hum. Genet. 48 (1991) 39-42
63. Moller H.E., Wiedermann D., Jurlemann G., Hilbih T., and Schuierer G. Application of NMR spectroscopy to monitoring MELAS treatment: a case report. Muscle Nerve 25 (2002) 593-600
64. Morava E., va den Heuvel L., Hol F., de Bries M.C., Hogeveen M., Rodenburg R.J., and Smeitink J.A.M. Mitochondrial disease criteria; diagnostic applications in children. Neurology 67 (2006) 1823-1826
65. Moroni I., Bugiani M., Bizzi A., Castelli G., Lamantea E., and Uziel G. Cerebral white matter involvement in children with mitochondrial encephalopathies. Neuropediatrics 33 (2002) 79-85
66. Munoz A., Mateos F., Simou R., Garcia-Silva M.T., Cabello S., and Arenas J. Mitochondrial diseases in children: neuroradiological and clinical features in 17 patients. Neuroradiology 41 (1999) 920-928
67. Naviaux R.K., and Nguyen K.V. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann. Neurol. 55 (2004) 706-712
68. Nakamura S., Yoshinari M., Wakisaka M., Kodera H., Doi Y., Yoshizumi H., Asano T., Iwase M., Mihara F., and Fujishima M. Ketoacidosis accompanied by epileptic seizures in a patient with diabetes mellitus and mitochondrial myopathy, encephalopathy lactic acidosis and stroke-like episodes (MELAS). Diabetes Metab. 26 (2000) 407-410
69. Nisho I., Spinazzola A., Papadimitriou A., Hammans S., Steiner I., Hahn C.D., Connolly A.M., Verloes A., Guimares J., Maillard I., Hamano H., Donati M.A., Semrad C.E., Russell J.A., Andreu A.L., Hadjigeorgiou G.M., Vu T.H., Tadesse S., Nygaard T.G., Nonaka I., Hirano I., Bonilla E., Rowland L.P., DiMauro S., and Hirano M. Mitochondrial neurogastroinstestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann. Neurol. 47 (2000) 792-800
70. Nissenkorn A., Zeharia A., Lev D., Watemberg N., Fattal-Valevski A., Barash V., Gutman A., Harel S., and Lerman-Sagie T. Neurologic presentations of mitochondrial disorders. J. Child Neurol. 15 (2000) 44-48
71. Nonaka I. Approach for a final diagnosis of mitochondrial disease. Nippon Rinsho 60 Suppl. 4 (2002) 224-228
72. Oppenheim C., Galanaud D., Samson Y., Sahel M., Dormont D., Wechsler B., and Marsault C. Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS?. J. Neurol. Neurosurg. Psychiatry 69 (2000) 248-250
73. Paviakis S.G., Phillips P.C., DiMauro S., De Vivo D.C., and Rowland L.P. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a distinctive clinical syndrome. Ann. Neurol. 16 (1984) 481-488
74. Pearson H.A., Lobel J.S., Kocoshis S.A., Naiman J.L., Windmiller J., Lammi A.T., Hoffman R., and Marsh J.C. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J. Pediatr. 95 (1979) 976-984
75. Pouwels P.J., and Frahm J. Regional metabolic concentrations in human brain as determined by quantitative localized proton MRS. Magn. Reson. Med. 39 (1998) 53-60
76. Rahman S., Brown R.M., Chong W.K., Wilson G.K., and Brown G.K. A SURF1 gene mutation presenting as isolated leukodystrophy. Ann. Neurol. 49 (2001) 797-800
77. Ribacoba R., Salas-Puig J., Gonzalez C., and Astudillo A. Characteristics of status epilepticus in MELAS. Analysis of four cases. Neurologia 21 (2006) 1-11
78. Ross B.D. Real or imaginary? Human metabolism through nuclear magnetism. IUBMB Life 50 (2000) 177-187
79. Ross B., and Bluml S. Magnetic resonance spectroscopy of the human brain. Anat. Rec. 265 (2001) 54-84
80. Rotig A., Colonna V., Bonnefont J.P., Blanch S., Fischer A., Saudubray J.M., and Munnich A. Mitochondrial DNA deletion in Pearson's marrow/pancrease syndrome. Lancet 1 (1989) 902-903
81. Rotig A., Cormier V., Blanche S., Bonnefont J.P., Ledeist F., Romero N., Schmitz J., Rustin P., Fischer A., Saudubray J.M., and Munnich A. Pearson's marrow-pancreas syndrome: a multisystem mitochondrial disorder in infancy. J. Clin. Invest. 86 (1990) 1601-1608
82. Saitoh S., Momoi M.Y., Yamagata T., Mori Y., and Imai M. Effects of dichloroacetate in three patients with MELAS. Neurology 50 (1998) 531-534
83. Saneto R.P., Cohen B.H., Ruggieri P., and Hoppel C.L. MRS detection of CNS lactate peaks in primary mitochondrial cytopathies. Neurology 56 Suppl. 3 (2001) A42
84. Scheper G.C., van der Klok T., van Andel R.J., van Berkel C.G.M., Sissler M., Smet J., Muravina T.I., Serkov S.V., Uziel G., Bugiani M., Schiffmann R., Krageloh-Mann I., Smeitink J.A.M., Florentz C., Van Coster R., Pronk J.C., and van der Knaap M.S. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat. Genet. 39 (2007) 534-539
85. Schlaug G., Siewert B., Benfield A., Edelman R.R., and Warach S. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology 49 (1997) 113-119
86. Schuelke M., Smeitink J., Mariman J., Loeffen J., Plecko B., Trijbels F., Stockler-Ipsiroghu S., and von den Heuvel L. Mutant NDUUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat. Genet. 21 (1999) 260-261
87. Seijo-Martinex M., Casstro del Rio M., Campos Y., Palau F., Arenas J., Teijeira S., Fernandez Hojas R., and Navarro C. Unusual clinical findings and complex III deficiency was reported in a family with myoclonic dystrophy. J. Neurol. Sci. 208 (2003) 87-91
88. Shoubridge E.A. Nuclear genetic defects of oxidative phosphorylation. Hum. Mol. Genet. 10 (2001) 2277-2284
89. Simon L., Horoupian D., Dorfman L., Markds M., Herrick M.K., Wasserstein P., and Smith M.E. Polyneuropathy, ophthalmoplegia, leukoencephalopathy and intestinal pseudo-obstruction: POLIP syndrome. Ann. Neurol. 28 (1990) 349-360
90. Takanashi J., Sugita K., Tanabe Y., Maemoto T., and Niimi H. Dichloroacetate treatment in Leigh syndrome caused by mitochondrial DNA mutation. J. Neurol. Sci. 145 (1997) 83-86
91. Thorburn D.R., Sugiana C., Salemi R., Kirby D.M., Worgan L., Ohtake A., and Ryan M.T. Biochemical and molecular diagnosis of mitochondrial respiratory chain disorders. Biochim. Biophys. Acta 1659 (2004) 121-128
92. Tzoulis C., Engelsen B.A., Tehstad W., Aasly J., Zeviana M., Winterthun S., Ferrari G., Aarseth J.H., and Bindoff L.A. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 129 (2006) 1685-1692
93. Ulmer S., Flemming K., Hahn A., Stephani U., and Jansen O. Detection of acute cytotoxic changes in progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome) using diffusion-weighted MRI and MR spectroscopy. J. Comput. Assist. Tomogr. 26 (2002) 641-646
94. Valanne L., Ketonen L., Majander A., Suomalainen A., and Pihko H. Neuroradiologic findings in children with mitochondrial disorders. AJNR Am. J. Neuroradiol. 19 (1998) 369-377
95. Van der Knaap M.S., van der Voorn P., Barkhof F., Van Coster R., Krageloh-Mann I., Feigenbaum A., Blaser S., Vies J.S.H., Rieckmann P., and Pouwels P.J.W. A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate. Ann. Neurol. 53 (2003) 252-258
96. van der Knaapp M.S., Jakobs C., and Valk J. Magnetic resonance imaging in lactic acidosis. J. Inherit. Metab. Dis. 19 (1996) 535-547
97. Walker U.A., Collins S., and Byrne E. Respiratory chain encephalomyopathies: a diagnostic classification. Eur. Neurol. 36 (1996) 260-267
98. Wilichowski E., Pouwels P.J., Frahm J., and Hanefeld F. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS. Neuropediatrics 30 (1999) 256-263
99. Wolf N.I., and Smeitnink J.A. Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology 59 (2002) 1402-1405
100. Wray S.H., Provenzale J.M., Johns D.R., and Thulborn K.R. MR of the brain in mitochondrial myopathy. AJNR Am. J. Neuroradiol. 16 (1995) 1167-1173
101. Yonenura K., Hasegawa Y., Kimura K., Minematsu K., and Yamaguchi T. Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. AJNR Am. J. Neuroradiol. 22 (2001) 269-272
102. Zafeirou D.I., Koletzko B., Mueller-Felber W., Paetzke I., Kueffer G., and Jensen M. Deficiency in complex IV (cytochrome c oxidase) of the respiratory chain, presenting as leukodystrophy in two siblings with Leigh syndrome. Brain Dev. 17 (1995) 117-121
103. Zeviani M., and Di Donato S. Mitochondrial Disord. Brain 127 (2004) 2153-2172
104. Zeviani M., Moraes C.T., DiMauaro S., Nakase H., Bonilla E., Schon E.A., and Rowland L.P. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 38 (1988) 1339-1346